tiprankstipranks
Advertisement
Advertisement

Cambridge Cognition Sets Date to Release 2025 Full-Year Results

Story Highlights
  • Cambridge Cognition develops digital cognitive assessment technology serving clinical, academic, healthcare and consumer markets worldwide.
  • The company will release its full-year 2025 financial results on 13 April 2026, guiding stakeholders on its growth trajectory.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cambridge Cognition Sets Date to Release 2025 Full-Year Results

Claim 55% Off TipRanks

Cambridge Cognition Holdings ( (GB:COG) ) just unveiled an announcement.

Cambridge Cognition Holdings, a neuroscience technology firm focused on digital cognitive assessment solutions for clinical trials, academic research, healthcare providers and consumer wellness, is building a global brand to address growing demand in brain health diagnosis and treatment. The company announced it will publish its financial results for the year ended 31 December 2025 on 13 April 2026, a key disclosure that will inform investors and stakeholders about its progress in scaling operations and executing its growth strategy across its identified market sectors.

The most recent analyst rating on (GB:COG) stock is a Hold with a £36.00 price target. To see the full list of analyst forecasts on Cambridge Cognition Holdings stock, see the GB:COG Stock Forecast page.

Spark’s Take on COG Stock

According to Spark, TipRanks’ AI Analyst, COG is a Neutral.

Overall score reflects weak financial performance driven by declining revenue, ongoing losses, and negative operating/free cash flow, partially offset by improved equity on the balance sheet. Technicals are mixed (short-term strength but longer-term downtrend and overbought RSI), while valuation is constrained by loss-making results and no stated dividend yield.

To see Spark’s full report on COG stock, click here.

More about Cambridge Cognition Holdings

Cambridge Cognition Holdings is a neuroscience technology company specialising in digital cognitive assessments that support scientific discovery, accelerate drug development and enhance patient care. Leveraging curated data and scalable technology, the company targets four key sectors: clinical pharmaceutical studies, academic CNS research, healthcare diagnostics, and consumer health and wellness tools for cognitive health monitoring.

Average Trading Volume: 33,718

Technical Sentiment Signal: Hold

Current Market Cap: £17.92M

For detailed information about COG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1